Deal Flow
Letter · prints on one page
Transaction tear sheetData as of Nov 7, 2026
M&A · Energy · Crude Petroleum & Natural Gas

Desert Peak Minerals to acquire Falcon Minerals Corp

Announced Jan 12, 2022 · Closed Jun 10, 2022

Deal value—
Premium—To unaffected price
EV / Adj. EBITDA—
ConsiderationAll stock

Transaction

Acquirer
Desert Peak Minerals
Target
Falcon Minerals Corp
Buyer type
Strategic
Offer price per share
—
Enterprise value
—
Status
Closed Jun 10, 2022

Deal protections

Break fee (target pays)
$13.9M
Reverse fee (buyer pays)
$13.9M
Go-shop
No-shop
Financing
—

Advisors

To the acquirer
Not disclosed
To the target
Barclays, Houlihan Lokey
Credit Suisse fee
$9.0M

Sector context · Energy

Comparable deals
25 in the prior 24 months
Premium
Sector median 20.6%
EV / Adj. EBITDA
Sector median 13.3x
Break fee
Sector median 2.6%

Timeline

  1. AnnouncedJan 12, 2022
  2. Proxy filedFeb 9, 2022
  3. Definitive proxyMay 5, 2022
  4. Shareholder voteJun 3, 2022
  5. ClosedJun 10, 2022

Valuation · fairness opinions

Trading comparablesCredit Suisse$25.47$30.19
Trading comparablesCredit Suisse$23.89$27.44
Discounted cash flowCredit Suisse$29.12$37.05
Discounted cash flowCredit Suisse$32.29$41.45
Discounted cash flowCredit Suisse$30.54$38.91
Discounted cash flowGoldman Sachs$24.57$32.30
Discounted cash flowGoldman Sachs$29.67$37.53
Discounted cash flowGoldman Sachs$21.71$27.17
Discounted cash flowGoldman Sachs$30.63$38.89
Premiums paidGoldman Sachs$27.16$30.31

Implied value per Falcon Minerals Corp share by analysis, from Credit Suisse and Goldman Sachs · DCF discount rate 8.5%–10.5%.

Sources
  • 8-K (EX-99.1) · Jan 12, 2022

Adj. EBITDA is operating income + D&A + impairment, restructuring, deal costs and stock compensation, less any large gain on a sale, last twelve months, from the target's filings. Calculated by Castle, so it can differ from a bank's adjusted figure.

Prepared with Castle from public SEC EDGAR filings. Figures are extracted automatically; verify against the source documents. Not investment advice.